Importantly, the numbers of CD8+ CAR T cells, known as a major population of tumour-killing cells, were higher owing to MWA in the combination group than in the AXL-CAR T monotherapy group (Fig. 4g, h). The gene discussed is CD8A; the disease is neoplasm.